Harrow Inc (HROW) Company Profile & Statistics

Harrow Inc
HROW
(Nasdaq - US)
Closed
43.93
+1.49 (+3.51%)
in:usd•As of: Nov 21, 2024 15:59 UTC -5
After Market:43.62-0.31 (-0.71%)
Open
42.95
High
44.26
Low
42.15

About Harrow Inc

CEO

Mark L. Baum

Headquarters

102 woodmont blvd., suite 610

nashville, tn 37205, united states

Auditor

KMJ Corbin & Company LLP

Employees

315

Share Holders

Website

www.harrow.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

Harrow Inc. is an eyecare pharmaceutical company. It engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products principally for the U.S. market. Harrow Inc., formerly known as Harrow Health Inc., is based in NASHVILLE, Tenn.

Harrow Inc Statistics

Valuation Measures

Market Capitalization ²	1.56B
Enterprise Value	1.68B
Enterprise Value/EBITDA (ttm)	200.79
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	24.45
Price to Sales (ttm)	8.36
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	72.10%
Operating Margin (ttm)	-16.60%
Profit Margin (ttm)	-21.54%
Return on Equity (ttm)	-45.57%
Return on Invested Capital (ttm)	-13.55%
Return on Assets (ttm)	-8.87%

Income Statement

Revenue (ttm)	169.14M
Revenue Per Share (ttm)	4.75
Gross Profit (ttm)	122.73M
EBITDA (ttm)³	8.36M
Net Income Avi to Common (ttm)	-33.41M
Diluted EPS (ttm)	-0.94

Share Statistics

Beta (5Y Monthly)	0.76
52-Week Change	364.38%
S&P500 52-Week Change	30.55%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	35.61M
Dividend Yield	0.00%
Float ⁴	30.75M
% Held by Insiders	13.67%
% Held by Institutions	72.76%

Balance Sheet

Total Cash (mrq)	72.60M
Total Cash Per Share (mrq)	2.04
Total Debt (mrq)	186.06M
Total Debt/Equity (mrq)	322.90%
Current Ratio (mrq)	1.55%
Quick Ratio (mrq)	1.44%
Book Value Per Share (mrq)	1.62

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.12
Free Cash Flow (ytd)	-5.46M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Harrow Inc

Trade With A Regulated Broker